---
schema_version: "secwatch.filing_event.v1"
accession: "0001464521-25-000018"
form_type: "8-K"
ticker: "HTFL"
cik: "0001464521"
company_name: "Heartflow, Inc."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:03:54.823233+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Heartflow Q3 revenue $46.3M (+41% YoY); initiates FY2025 guidance $173.0M-$173.5M

## Summary
- Net loss $50.9M ($1.04/share) includes $32.1M warrant remeasurement; non-GAAP net loss $13.2M ($0.27/share).
- Gross margin 76.5% (non-GAAP 76.8%); net operating loss $15.1M (non-GAAP $11.1M).
- UnitedHealthcare and Cigna began covering Heartflow Plaque Analysis on Oct 1, 2025.
- IPO raised ~$364.2M in gross proceeds; cash $291.2M at Sept 30 after debt repayments.
- Full year 2025 revenue guidance $173.0M-$173.5M; warrants fully exercised post-quarter.

## SEC filing metadata
- accession: 0001464521-25-000018
- form_type: 8-K
- ticker: HTFL
- cik: 0001464521
- company_name: Heartflow, Inc.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1464521/000146452125000018/0001464521-25-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1464521/000146452125000018/htfl-20251112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001464521-25-000018
- JSON: https://secwatch.observer/filing/0001464521-25-000018.json
- Plain text: https://secwatch.observer/filing/0001464521-25-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.